Consolidated Balance Sheets - USD ($)
|
Dec. 31, 2019 |
Dec. 31, 2018 |
| Current Assets |
|
|
| Cash |
|
$ 56,823
|
| Accounts and other receivables, net |
18,136
|
24,553
|
| Inventory |
4,334
|
36,694
|
| Prepaid expenses and deposits |
4,013
|
27,997
|
| Total Current Assets |
26,483
|
146,067
|
| Goodwill |
505,508
|
505,508
|
| Total Assets |
531,991
|
651,575
|
| Current Liabilities |
|
|
| Accounts payable and accrued liabilities |
983,358
|
813,682
|
| Current portion of deferred revenue, net of contract assets |
207,566
|
317,070
|
| Convertible debentures and accrued interest, net of unamortized discount of $343,398 and $0, respectively |
21,121
|
|
| Derivative liabilities |
92,322
|
|
| Total Current Liabilities |
1,304,367
|
1,130,752
|
| Deferred revenue, net of contract assets |
54,899
|
77,362
|
| Total Liabilities |
1,359,266
|
1,208,411
|
| Commitments and Contingencies |
|
|
| Redeemable convertible preferred stock - Series A:Authorized - 1,250,000 shares with $0.001 par value, 160,600 shares and no shares issued and outstanding as of December 31, 2019 and 2018, respectively, aggregate liquidation preference of $153,862 as of December 31, 2019, net of discount of $121,931 |
31,927
|
|
| Stockholders' Deficit |
|
|
| Common stock: Authorized - 375,000,000 shares with $0.001 par value issued and outstanding - 74,242,196 and 66,714,970 shares, respectively |
74,242
|
66,715
|
| Additional paid-in capital |
10,697,216
|
10,426,245
|
| Accumulated deficit |
(11,630,660)
|
(11,049,499)
|
| Total Stockholders' Deficit |
(859,202)
|
(556,539)
|
| Total Liabilities and Stockholders' Deficit |
$ 531,991
|
$ 651,575
|